🇯🇵 腎機能と全身の健康に関わる生体調節メカニズムの概要

עברית, Spanish – EspañolРусскийDeutschEnglish, 日本語.

慢性腎臓病は一般に機能低下の進行として理解されますが、近年の研究では、生体内の調節・維持機構が重要な役割を果たすことが示唆されています。

本稿では、エネルギー代謝、細胞保護とクリアランス、血流と全身環境という三つの軸から、腎機能を支えるメカニズムを整理します。

(※ 生体の内在的な調節機構に着目した概念モデル)


The following table summarizes key biological pathways discussed in the literature.


📊 Table: Key Biological Pathways in Kidney Function and Their Potential Modulation

PathwayPrimary Role in Kidney FunctionPotential Modulation (Natural Interventions)Additional Organs Affected
AMPK → SIRT1 → PGC-1αMitochondrial biogenesis; protection of podocytes and tubular cellsResveratrol; light physical activity (e.g., walking); intermittent fastingHeart, brain, liver, lungs
Nrf2–Keap1Antioxidant defense; detoxification; inflammation reductionSulforaphane (broccoli sprouts); curcuminGut barrier, liver, heart, brain, lungs
Mitophagy / Autophagy + TFEBRemoval of damaged mitochondria and cellular debrisUrolithin A (pomegranate derivatives); resveratrol; sulforaphaneLiver, heart, brain, lungs, gut
FGF23–KlothoPhosphate–calcium balance; anti-fibrotic; anti-aging effectsVitamin D3 (controlled dosing); resveratrol; sulforaphane; physical activityHeart (reduced calcification), brain, lungs
Gut–Kidney AxisReduction of systemic inflammation; decreased toxin load (e.g., TMAO); gut barrier supportSulforaphane; urolithin A; targeted probioticsGut, liver, heart, brain, lungs
HPT Axis (Thyroid)Regulation of metabolic rate and mitochondrial activity (T3)Resveratrol; sulforaphane; physical activityHeart, brain, liver, lungs
mTORC1Regulation of cellular growth; chronic overactivation linked to fibrosisMild inhibition via AMPK activation (resveratrol; sulforaphane)Heart, liver, skeletal muscle
Wnt/β-cateninChronic activation linked to fibrosis and podocyte injuryResveratrol; curcumin; sulforaphaneHeart, liver, lungs, brain
NO / eNOSVascular dilation; improved renal blood flow; endothelial protectionPolyphenols (e.g., resveratrol); plant-derived compounds (e.g., Opuntia ficus-indica)Heart, brain, lungs, liver, gut
Irisin / FNDC5Myokine-mediated protection of kidney cells; podocyte supportPhysical activity; PGC-1α activationBrain (BDNF), heart, liver, lungs
PPARαFatty acid oxidation in renal cells; prevention of lipotoxicityResveratrol; sulforaphane; physical activityLiver, heart, brain
Epigenetic RegulationLong-term gene expression modulation; cellular memorySIRT1 activation (resveratrol); sulforaphane; physical activitySystem-wide
Vitamin D / VDRDirect activation of Klotho; podocyte protection; anti-inflammatory effectsVitamin D3 (monitored dosing); controlled sun exposureBrain, heart, lungs, gut, bone

本表は教育的・概念的な整理を目的としており、特定の治療を推奨するものではありません。

עברית, Spanish – EspañolРусскийDeutschEnglish


📚 参考文献(References)

🔋 エネルギー代謝と再生(Energy and Regeneration)

  1. Hallan S, Sharma K. The role of mitochondria in diabetic kidney disease. Nat Rev Nephrol.
  2. Bhargava P, Schnellmann RG. Mitochondrial energetics in the kidney. Nat Rev Nephrol.
  3. Hardie DG. AMPK: a key regulator of energy balance in the kidney. Physiol Rev.
  4. Cantó C, Auwerx J. Targeting sirtuin 1 to improve metabolism. Nat Rev Drug Discov.
  5. Hasegawa K et al. SIRT1 protects against oxidative stress in kidney disease. J Am Soc Nephrol.
  6. Scarpulla RC. PGC-1α and mitochondrial biogenesis. Cell Metab.
  7. Kume S et al. Role of nutrient-sensing pathways in diabetic nephropathy. J Am Soc Nephrol.
  8. Martins R et al. FOXO proteins and aging. Aging Cell.
  9. Cheng Z et al. SIRT1/FOXO pathway in renal protection. Kidney Int.
  10. Verdin E. NAD⁺ metabolism and aging. Science.

🛡️ 細胞保護とクリアランス(Protection and Clearance)

  1. Yamamoto M et al. The KEAP1–NRF2 system: a master regulator of oxidative stress. Physiol Rev.
  2. Ruiz S et al. Targeting the Nrf2 pathway in kidney disease. Kidney Int.
  3. Ding Y, Choi ME. Autophagy in diabetic nephropathy. J Endocrinol.
  4. Livingston MJ et al. Autophagy in acute kidney injury and repair. J Clin Invest.
  5. Kimura T et al. Autophagy and the kidney. Nat Rev Nephrol.
  6. Pickles S et al. Mitophagy and mitochondrial quality control. Nat Rev Mol Cell Biol.
  7. Settembre C et al. TFEB links autophagy to lysosomal biogenesis. Science.
  8. Mizushima N. Autophagy: process and function. Genes Dev.

🌊 環境・血流・全身相互作用(Environment, Flow, and Systemic Interaction)

  1. Förstermann U, Sessa WC. Nitric oxide synthases: regulation and function. Eur Heart J.
  2. Vanhoutte PM et al. Endothelial dysfunction and vascular disease. Acta Physiol.
  3. Crowley SD, Coffman TM. The inextricable role of the kidney in hypertension. J Clin Invest.
  4. Mezzano SA et al. Renin-angiotensin system and renal fibrosis. Kidney Int Suppl.
  5. Fine LG, Norman JT. Chronic hypoxia as a mechanism of kidney disease progression. Kidney Int.
  6. Haase VH. Hypoxia-inducible factors in kidney disease. J Am Soc Nephrol.
  7. Ruiz-Ortega M et al. TGF-β signaling in renal fibrosis. Nat Rev Nephrol.
  8. Evenepoel P et al. The gut-kidney axis. Nat Rev Nephrol.
  9. Vaziri ND et al. CKD alters gut microbiome and toxin generation. Kidney Int.
  10. Tang WHW et al. Gut microbiota and cardiovascular disease (TMAO pathway). N Engl J Med.

🔹 慢性腎疾患および線維化に関する補足文献(CKD and Fibrosis)

  1. Kalantar-Zadeh K et al. Chronic kidney disease. Lancet.
  2. Levin A et al. Kidney disease: global burden and management. Lancet.
  3. Ruiz S, Pergola PE, Zager RA. Targeting oxidative stress in CKD. Kidney Int.
  4. Nath KA. Tubulointerstitial changes as a major determinant in CKD. Kidney Int.
  5. Friedman SL et al. Mechanisms of fibrosis across organs. J Clin Invest.



ご質問はありますか?

以下の連絡先を通じて、ヤロン・マルゴリンにお問い合わせください。

    שמי Name:


    טלפון phone:


    דוא"ל (כדי שאוכל להשיב לך מכל מקום בעולם) Email:


    איך אני יכול לעזור לך How can I help you:


    אפשר לקבל את בדיקות הדם החריגות שלך Exceptional laboratory tests:


    ご注意ください:

    ご自身、またはご家族の健康状態に関連するすべての製品(食品、抽出物、サプリメント、クリーム、運動など)をご使用になる前に、必ず信頼できる医師または薬剤師にご相談ください。

    ヤロン・マルゴリンは元ダンサーであり、1980年代半ばにエルサレムで独自の身体アプローチを展開しました。
    舞台から引退後は、慢性疾患、特に腎機能に関する実践的な取り組みに関わるようになり、身体に本来備わる調節・回復メカニズムに着目した視点を発展させてきました。
    彼のアプローチは、従来の治療を置き換えるものではなく、生体内の維持・調整機構を理解するための補完的な枠組みとして位置づけられています。

    彼のウェブサイト(YARONMARGOLIN.COM)、フェイスブックページ「癒しの圧法」や本記事、およびその他の論文に記載されている情報は、「考察のための哲学的資料」であり、医療上の推奨や指導ではありません。

    このサイト、または関連するすべての資料は、処方薬の使用または中止に関する代替となるものではなく、健康に関して決定を行うための唯一の情報源とすべきではありません。

    不調、痛み、使用目的に関しては、常に資格のある専門医または薬剤師と相談してください。


    このテーマに関するヤロン・マーゴリンによるヘブライ語と英語の記事

    אחרונים


    נשלח ב כללי

    🇬🇧 Understanding Intrinsic Regulatory Mechanisms:


    Relevance for Kidneys, Heart, Brain and Other Organ Systems

    עבריתSpanish – EspañolРусский, Deutsch, English


    How the Body Activates Repair Mechanisms – with a Focus on the Kidneys


    ✍️ Personal Introduction

    This article emerges from a long personal engagement with chronic illness and from a continuous search for pathways of recovery that go beyond merely slowing disease progression, aiming instead to understand how the body repairs itself, renews, and restores function.

    Over the years, through practice, observation, and the study of scientific literature, a central insight has taken shape:
    the body does not operate solely through mechanisms of disease, but also through a complex network of maintenance, cleansing, and regenerative pathways.

    When these pathways weaken, disease develops.
    When they are reactivated, a window for recovery may open.

    The problem is not only the disease itself —
    but that we are rarely taught how and why the body stops repairing.


    📄 Abstract

    This article presents an integrative model for understanding chronic kidney disease (CKD), not only as a process of cumulative damage, but also as a decline in the activity of biological systems responsible for maintenance and regeneration.

    The model is structured around three core axes:
    energy and regeneration, protection and cleansing, and environment and flow.

    This perspective does not replace conventional medical care, but complements it by highlighting the role of intrinsic repair mechanisms.


    🧠 Introduction

    The kidney is often viewed as a filtration organ.
    In reality, it is a complex metabolic system that depends on a finely tuned balance between energy supply, blood flow, cellular cleansing, and hormonal signaling.

    Chronic kidney disease is characterized by:

    • mitochondrial dysfunction
    • oxidative stress
    • progressive fibrosis
      (29,32)

    Conventional clinical approaches primarily focus on slowing disease progression (30).

    However, growing scientific evidence suggests that cellular maintenance and regenerative mechanisms play a critical role in influencing disease trajectory.


    🔋 Axis 1: Energy and Regeneration

    Mitochondrial dysfunction is a central feature of CKD (1,2).

    AMPK acts as a key energy sensor, and its activation is associated with improved cellular function and reduced oxidative stress (3).

    NAD⁺ enables the activity of SIRT1, which contributes to protection against inflammatory and oxidative damage (5,10).
    PGC-1α is a central regulator of mitochondrial biogenesis (6), while FOXO is involved in the expression of genes related to cellular protection and survival (8,9).

    Interventions such as intermittent fasting and physical activity have been associated with the activation of these pathways (4,7).
    (in simple terms: states that mildly challenge energy balance may help “switch on” cellular adaptation systems)


    🛡️ Axis 2: Protection and Cleansing

    The Nrf2 pathway is a central regulator of antioxidant defense (11), and its activation has been associated with reduced kidney damage (12).

    Reduced autophagy contributes to the accumulation of cellular damage and disease progression (15,13).

    Autophagy and mitophagy enable the removal of damaged cellular components and support the maintenance of cellular homeostasis (16).
    (in simple terms: the cell’s internal “cleaning and recycling” system)

    TFEB acts as a key regulator of cellular clearance systems (17), while autophagy remains fundamental for cellular integrity (18,14).


    🌊 Axis 3: Environment and Flow

    Nitric oxide (NO) plays a central role in regulating vascular tone and blood flow (19).
    Endothelial dysfunction is closely associated with CKD progression (20).

    The RAAS system is essential for blood pressure regulation, but its chronic activation contributes to renal fibrosis (21,22).

    Hypoxia is a key driver of kidney damage (23), while HIF-1α enables cellular adaptation to low oxygen conditions (24).

    In addition, the gut–kidney axis influences toxin load and systemic inflammation (26,27).
    Metabolites such as TMAO have been associated with cardiovascular and renal damage (28).

    The TGF-β pathway is directly involved in the development of renal fibrosis (25).

    Scientific evidence suggests that targeted and well-adapted interventions may support these fundamental maintenance and repair mechanisms.


    🔄 Discussion

    This model represents a conceptual shift:
    from a damage-centered perspective toward one based on systems of maintenance and repair.

    The three axes interact in an integrated manner:

    • Energy and regeneration → sustain cellular function
    • Protection and cleansing → prevent accumulation of damage
    • Environment and flow → create the conditions necessary for recovery

    While scientific literature supports each of these mechanisms individually, their integration provides a broader and more practical framework.


    ⚖️ Clinical Significance

    This approach does not contradict standard medical therapy, but rather complements it.

    The combination of conventional treatment with the support of intrinsic biological mechanisms may contribute to improved clinical outcomes and open new perspectives in the management of chronic diseases — including those affecting the heart, liver, lungs, digestive system, brain, and kidneys.

    Certain natural compounds such as resveratrol, curcumin, and plant-derived bioactive substances (e.g., quercetin) are discussed in the scientific literature as potential modulators of these pathways.

    Resveratrol, in particular, has been associated with pathways involved in cellular stress adaptation and metabolic regulation.


    🌿 Illustrative Examples

    🛡️ Protection and Cleansing

    One example is the activation of antioxidant defenses via the Nrf2 pathway.

    Sulforaphane, found in broccoli sprouts, has been associated in research with activation of this system and enhanced cellular protection against oxidative stress.


    🔋 Energy and Regeneration

    Another example relates to cellular energy metabolism.

    Resveratrol has been associated with activation of SIRT1 and improved mitochondrial function, potentially contributing to energy balance stability.


    🌊 Flow and Functional Environment

    Vascular function is also critical.

    Nitric oxide (NO) is essential for vascular dilation and proper kidney perfusion.

    Plant-based foods such as prickly pear (Opuntia ficus-indica) are being investigated for their potential effects on metabolism and vascular function.


    🧠 Additional Perspective (based on reader feedback)

    A recurring point in reader responses is the desire for concrete examples of how these biological mechanisms can be supported in daily life.

    This highlights an important aspect:
    understanding mechanisms alone is not sufficient — what matters is translating them into meaningful contexts.

    For example:

    • Certain plant compounds are studied in relation to the activation of cellular defense systems.
    • Metabolic adaptations, such as those induced by physical activity or periods of reduced energy intake, are linked to cellular energy regulation.
    • Maintaining vascular health directly influences blood flow and oxygen delivery to the kidneys.

    These examples are not intended as therapeutic prescriptions, but rather to illustrate how closely lifestyle factors are connected to biological regulatory systems.


    🔚 Closing Perspective

    This perspective suggests that even fundamental aspects of lifestyle may influence how effectively intrinsic regulatory mechanisms operate.


    🌱 A Path of Hope

    Recovery may be possible.
    This work invites a shift in perspective — toward knowledge, awareness, and a deeper understanding that the body possesses the capacity for adaptation and regeneration.


    ⚠️ Disclaimer

    All information presented here is intended for educational and conceptual purposes.
    It does not replace medical advice. Always consult a qualified healthcare professional before starting, modifying, or discontinuing any treatment.

    עבריתSpanish – EspañolРусский, Deutsch, English


    📊 Table: Key Biological Pathways in Kidney Function and Their Potential Modulation

    PathwayPrimary Role in Kidney FunctionPotential Modulation (Natural Interventions)Additional Organs Affected
    AMPK → SIRT1 → PGC-1αMitochondrial biogenesis; protection of podocytes and tubular cellsResveratrol; light physical activity (e.g., walking); intermittent fastingHeart, brain, liver, lungs
    Nrf2–Keap1Antioxidant defense; detoxification; inflammation reductionSulforaphane (broccoli sprouts); curcuminGut barrier, liver, heart, brain, lungs
    Mitophagy / Autophagy + TFEBRemoval of damaged mitochondria and cellular debrisUrolithin A (pomegranate peel derivatives); resveratrol; sulforaphaneLiver, heart, brain, lungs, gut
    FGF23–KlothoPhosphate–calcium balance; anti-fibrotic; anti-aging effectsVitamin D3 (controlled dosing); resveratrol; sulforaphane; physical activityHeart (reduced calcification), brain, lungs
    Gut–Kidney AxisReduction of systemic inflammation; decreased toxin load (e.g., TMAO); gut barrier supportSulforaphane; urolithin A; targeted probioticsGut, liver, heart, brain, lungs
    HPT Axis (Thyroid)Regulation of metabolic rate and mitochondrial activity (T3)Resveratrol; sulforaphane; physical activityHeart, brain, liver, lungs
    mTORC1Regulation of cellular growth; chronic overactivation linked to fibrosisMild inhibition via AMPK activation (resveratrol; sulforaphane)Heart, liver, skeletal muscle
    Wnt/β-cateninChronic activation linked to fibrosis and podocyte injuryResveratrol; curcumin; sulforaphaneHeart, liver, lungs, brain
    NO / eNOSVascular dilation; improved renal blood flow; endothelial protectionPolyphenols (e.g., resveratrol); plant-derived compounds (e.g., from Opuntia ficus-indica)Heart, brain, lungs, liver, gut
    Irisin / FNDC5Myokine-mediated protection of kidney cells; podocyte supportPhysical activity; PGC-1α activationBrain (BDNF), heart, liver, lungs
    PPARαFatty acid oxidation in renal cells; prevention of lipotoxicityResveratrol; sulforaphane; physical activityLiver, heart, brain
    Epigenetic RegulationLong-term gene expression modulation; cellular memorySIRT1 activation (resveratrol); sulforaphane; physical activitySystem-wide
    Vitamin D / VDRDirect activation of Klotho; podocyte protection; anti-inflammatory effectsVitamin D3 (monitored dosing); controlled sun exposureBrain, heart, lungs, gut, bone

    ✔ Note: The pathways and interventions listed are based on associations reported in scientific literature and are presented for conceptual and educational purposes. They do not constitute medical recommendations.

    עברית, Spanish – EspañolРусский, Deutsch, English


    📚 References – Atlas of Recovery Pathways


    🔋 Axis 1: Energy and Regeneration

    AMPK / NAD⁺ / SIRT1 / PGC-1α / FOXO

    1. Hallan S, Sharma K. The role of mitochondria in diabetic kidney disease. Nat Rev Nephrol.
    2. Bhargava P, Schnellmann RG. Mitochondrial energetics in the kidney. Nat Rev Nephrol.
    3. Hardie DG. AMPK: a key regulator of energy balance in the kidney. Physiol Rev.
    4. Cantó C, Auwerx J. Targeting sirtuin 1 to improve metabolism. Nat Rev Drug Discov.
    5. Hasegawa K et al. SIRT1 protects against oxidative stress in kidney disease. J Am Soc Nephrol.
    6. Scarpulla RC. PGC-1α and mitochondrial biogenesis. Cell Metab.
    7. Kume S et al. Role of nutrient-sensing pathways in diabetic nephropathy. J Am Soc Nephrol.
    8. Martins R et al. FOXO proteins and aging. Aging Cell.
    9. Cheng Z et al. SIRT1/FOXO pathway in renal protection. Kidney Int.
    10. Verdin E. NAD⁺ metabolism and aging. Science.

    🛡️ Axis 2: Protection and Cleansing

    Nrf2 / Autophagy / Mitophagy / TFEB

    1. Yamamoto M et al. The KEAP1–NRF2 system: a master regulator of oxidative stress. Physiol Rev.
    2. Ruiz S et al. Targeting the Nrf2 pathway in kidney disease. Kidney Int.
    3. Ding Y, Choi ME. Autophagy in diabetic nephropathy. J Endocrinol.
    4. Livingston MJ et al. Autophagy in acute kidney injury and repair. J Clin Invest.
    5. Kimura T et al. Autophagy and the kidney. Nat Rev Nephrol.
    6. Pickles S et al. Mitophagy and mitochondrial quality control. Nat Rev Mol Cell Biol.
    7. Settembre C et al. TFEB links autophagy to lysosomal biogenesis. Science.
    8. Mizushima N. Autophagy: process and function. Genes Dev.

    🌊 Axis 3: Environment and Flow

    NO / eNOS / RAAS / HIF-1α / Gut–Kidney Axis

    1. Förstermann U, Sessa WC. Nitric oxide synthases: regulation and function. Eur Heart J.
    2. Vanhoutte PM et al. Endothelial dysfunction and vascular disease. Acta Physiol.
    3. Crowley SD, Coffman TM. The inextricable role of the kidney in hypertension. J Clin Invest.
    4. Mezzano SA et al. Renin–angiotensin system and renal fibrosis. Kidney Int Suppl.
    5. Fine LG, Norman JT. Chronic hypoxia as a mechanism of kidney disease progression. Kidney Int.
    6. Haase VH. Hypoxia-inducible factors in kidney disease. J Am Soc Nephrol.
    7. Ruiz-Ortega M et al. TGF-β signaling in renal fibrosis. Nat Rev Nephrol.
    8. Evenepoel P et al. The gut–kidney axis. Nat Rev Nephrol.
    9. Vaziri ND et al. Chronic kidney disease alters gut microbiome and toxin generation. Kidney Int.
    10. Tang WHW et al. Gut microbiota and cardiovascular disease (TMAO pathway). N Engl J Med.

    🔹 Additional References on CKD and Fibrosis

    1. Kalantar-Zadeh K et al. Chronic kidney disease. Lancet.
    2. Levin A et al. Kidney disease: global burden and management. Lancet.
    3. Ruiz S, Pergola PE, Zager RA. Targeting oxidative stress in chronic kidney disease. Kidney Int.
    4. Nath KA. Tubulointerstitial changes as a major determinant in chronic kidney disease. Kidney Int.
    5. Friedman SL et al. Mechanisms of fibrosis across organs. J Clin Invest.

    For support, inspiration, and success stories, visit yaronmargolin.com or explore the healing touch method at yaronmargolin.com or the "לחיצות ההחלמה" To contact us.

    עבריתSpanish – EspañolРусский, Deutsch, English

      שמי Name:


      טלפון phone:


      דוא"ל (כדי שאוכל להשיב לך מכל מקום בעולם) Email:


      איך אני יכול לעזור לך How can I help you:


      אפשר לקבל את בדיקות הדם החריגות שלך Exceptional laboratory tests:


      Important Note
      The information presented here is for educational and philosophical purposes only and does not replace medical advice. Always consult a licensed healthcare provider familiar with your individual health status before making changes to your regimen.

      More articles


      נשלח ב כללי